Savara (SVRA) Accumulated Depreciation (2011 - 2025)
Savara's (SVRA) quarterly Accumulated Depreciation came in at $2.3 million in Q4 2025, up 7.91% year-on-year from $2.2 million in Q4 2024, and up 7.91% on a QoQ basis from $2.2 million in Q4 2024.
Savara (SVRA) Accumulated Depreciation (2011 - 2025) Analysis & Trends
Savara (SVRA) has 15 years of Accumulated Depreciation data on file, last reported at $2.3 million in Q4 2025.
- On a quarterly basis, Accumulated Depreciation rose 7.91% year-over-year to $2.3 million in Q4 2025; TTM through Dec 2025 was $2.3 million, a 7.91% increase from a year earlier, with the FY2025 full-year figure at $2.3 million, up 7.91% from the prior year.
- Accumulated Depreciation for Q4 2025 stood at $2.3 million, up from $2.2 million in the prior quarter.
- Over the last five years, Accumulated Depreciation for SVRA reached as high as $2.3 million in Q4 2025 and fell as low as $1.9 million in Q4 2022.
- Historically, Accumulated Depreciation has averaged $2.1 million across 5 years, with a median of $2.1 million in 2021.
- Across the five-year window, Accumulated Depreciation retreated 7.5% in 2022 and rose 7.91% in 2025, its largest moves.
- Year by year, Accumulated Depreciation stood at $2.1 million in 2021, then slipped by 7.5% to $1.9 million in 2022, then gained by 4.63% to $2.0 million in 2023, then grew by 7.46% to $2.2 million in 2024, then grew by 7.91% to $2.3 million in 2025.
- Per Business Quant data, the three most recent Accumulated Depreciation figures were $2.3 million in Q4 2025, $2.2 million in Q4 2024, and $2.0 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.33 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Dec 31, 2023 | 2.01 Mn |
| Dec 31, 2022 | 1.92 Mn |
| Dec 31, 2021 | 2.08 Mn |
| Dec 31, 2020 | 1.97 Mn |
| Dec 31, 2019 | 1.67 Mn |
| Dec 31, 2018 | 1.37 Mn |
| Dec 31, 2017 | 851,000.00 |
| Dec 31, 2016 | 504,000.00 |
| Dec 31, 2015 | 339,000.00 |
| Dec 31, 2014 | 344,000.00 |
| Dec 31, 2013 | 262,000.00 |
| Dec 31, 2012 | 320,545.00 |
| Dec 31, 2011 | 274,187.00 |